SOLIGENIX, INC. Increase (Decrease) in Other Receivables
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Other Receivables of -$48.64 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-03-31
- SOLIGENIX, INC. increase (decrease) in other receivables for the quarter ending 2024-12-31 was $3.24K, a 55.88% increase year-over-year.
- SOLIGENIX, INC. increase (decrease) in other receivables for the quarter ending 2024-09-30 was -$2.88K, a 266.86% decline year-over-year.
- SOLIGENIX, INC. increase (decrease) in other receivables for the quarter ending 2024-06-30 was -$31.61K, a 782.09% decline year-over-year.
- SOLIGENIX, INC. increase (decrease) in other receivables for the quarter ending 2024-03-31 was -$17.38K.
- SOLIGENIX, INC. increase (decrease) in other receivables for fiscal 2024 was -$48.64K.
- SOLIGENIX, INC. increase (decrease) in other receivables for fiscal 2023 was -$90.02K.
- SOLIGENIX, INC. increase (decrease) in other receivables for fiscal 2022 was -$73.37K.
- SOLIGENIX, INC. increase (decrease) in other receivables for fiscal 2021 was -$205.24K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $351.00 derived: sum of 2 quarters · filed 2026-03-31 | -$31.26K derived: sum of 3 quarters · filed 2026-03-31 | -$48.64K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$2.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$34.50K derived: sum of 2 quarters · filed 2025-11-07 | -$51.88K 10-Q · filed 2025-11-07 | -$49.80K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$31.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$48.99K 10-Q · filed 2025-08-14 | -$46.92K derived: sum of 3 quarters · filed 2025-08-14 | -$45.19K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$17.38K 10-Q · filed 2025-05-09 | -$15.30K derived: sum of 2 quarters · filed 2025-05-09 | -$13.57K derived: sum of 3 quarters · filed 2025-05-09 | -$8.94K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $2.08K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $3.81K derived: sum of 2 quarters · filed 2025-03-21 | $8.44K derived: sum of 3 quarters · filed 2025-03-21 | -$90.02K 10-K · filed 2025-03-21 |
| 2023-09-30 | $1.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.36K derived: sum of 2 quarters · filed 2024-11-08 | -$92.09K 10-Q · filed 2024-11-08 | -$97.55K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $4.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$93.82K 10-Q · filed 2024-08-09 | -$99.28K derived: sum of 3 quarters · filed 2024-08-09 | -$96.86K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$98.46K 10-Q · filed 2024-05-10 | -$103.92K derived: sum of 2 quarters · filed 2024-05-10 | -$101.50K derived: sum of 3 quarters · filed 2024-05-10 | -$116.36K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$5.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$3.04K derived: sum of 2 quarters · filed 2024-03-15 | -$17.91K derived: sum of 3 quarters · filed 2024-03-15 | -$73.37K 10-K · filed 2024-03-15 |
| 2022-09-30 | $2.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$12.45K derived: sum of 2 quarters · filed 2023-11-13 | -$67.91K 10-Q · filed 2023-11-13 | -$14.64K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$14.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$70.33K 10-Q · filed 2023-08-21 | -$17.06K derived: sum of 3 quarters · filed 2023-08-21 | $31.08K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | -$55.47K 10-Q · filed 2023-05-15 | -$2.19K derived: sum of 2 quarters · filed 2023-05-15 | $45.95K derived: sum of 3 quarters · filed 2023-05-15 | $66.59K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $53.27K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $101.41K derived: sum of 2 quarters · filed 2023-03-31 | $122.06K derived: sum of 3 quarters · filed 2023-03-31 | -$205.24K 10-K · filed 2023-03-31 |
| 2021-09-30 | $48.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $68.78K derived: sum of 2 quarters · filed 2022-11-10 | -$258.51K 10-Q · filed 2022-11-10 | -$285.60K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $20.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$306.65K 10-Q · filed 2022-08-12 | -$333.74K derived: sum of 3 quarters · filed 2022-08-12 | -$308.82K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$327.29K 10-Q · filed 2022-05-13 | -$354.38K derived: sum of 2 quarters · filed 2022-05-13 | -$329.46K derived: sum of 3 quarters · filed 2022-05-13 | -$406.07K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$27.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$2.17K derived: sum of 2 quarters · filed 2022-03-29 | -$78.77K derived: sum of 3 quarters · filed 2022-03-29 | -$21.92K 10-K · filed 2022-03-29 |
| 2020-09-30 | $24.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$51.69K derived: sum of 2 quarters · filed 2021-11-12 | $5.16K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$76.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$19.75K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $56.85K 10-Q · filed 2021-05-18 | |||
| 2019-12-31 | $444.04K 10-K · filed 2021-03-30 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$574.16K 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | -$574.16K 10-Q · filed 2013-08-12 | |||
| 2011-09-30 | -$4.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$251.86K 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | -$247.54K 10-Q · filed 2012-08-10 | |||
| 2010-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $8.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |